Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 392

Similar articles for PubMed (Select 22343969)

1.

Time trends in systemic thrombolysis in a large hospital-based stroke registry.

Singer OC, Hamann GF, Misselwitz B, Steinmetz H, Foerch C; Arbeitsgruppe Schlaganfall Hessen.

Cerebrovasc Dis. 2012;33(4):316-21. doi: 10.1159/000335816. Epub 2012 Feb 15.

PMID:
22343969
2.

Acute stroke management in the elderly.

Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD.

Cerebrovasc Dis. 2007;23(4):304-8. Epub 2006 Dec 29.

PMID:
17199089
3.

Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy.

Jauss M, Schütz HJ, Tanislav C, Misselwitz B, Rosenow F.

Eur J Neurol. 2010 Apr;17(4):555-61. doi: 10.1111/j.1468-1331.2009.02845.x. Epub 2010 Feb 10.

PMID:
20218973
4.

Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.

Minnerup J, Wersching H, Ringelstein EB, Schilling M, Schäbitz WR, Wellmann J, Berger K.

Stroke. 2011 Oct;42(10):2838-43. doi: 10.1161/STROKEAHA.111.616565. Epub 2011 Aug 18.

5.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

6.

Future demographic trends decrease the proportion of ischemic stroke patients receiving thrombolytic therapy: a call to set-up therapeutic studies in the very old.

Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T; Arbeitsgruppe Schlaganfall Hessen.

Stroke. 2009 May;40(5):1900-2. doi: 10.1161/STROKEAHA.108.531061. Epub 2009 Feb 26.

7.

Intravenous thrombolysis in German stroke units before and after regulatory approval of recombinant tissue plasminogen activator.

Weimar C, Kraywinkel K, Maschke M, Diener HC; German Stroke Study Collaboration.

Cerebrovasc Dis. 2006;22(5-6):429-31. Epub 2006 Aug 11.

PMID:
16912477
8.

Paul Coverdell National Acute Stroke Registry Surveillance - four states, 2005-2007.

George MG, Tong X, McGruder H, Yoon P, Rosamond W, Winquist A, Hinchey J, Wall HK, Pandey DK; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2009 Nov 6;58(7):1-23.

9.

Evaluation of applied cases of thrombolytic therapy against ultra-acute ischemic stroke. Using the Japanese Standard Stroke Registry Database.

Shiotsuki H, Ogushi Y, Fushimi K, Kobayashi S; Japanese Standard Stroke Registry Study (JSSRS) Group.

Tokai J Exp Clin Med. 2005 Apr;30(1):49-62.

PMID:
15952299
10.

Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.

Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.

Cerebrovasc Dis. 2012;34(5-6):400-5. doi: 10.1159/000343504. Epub 2012 Dec 4.

PMID:
23221276
11.

Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.

California Acute Stroke Pilot Registry (CASPR) Investigators.

Neurology. 2005 Feb 22;64(4):654-9.

PMID:
15728287
12.
13.

Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group.

Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, Buecker-Nott HJ, Rother J, Neundoerfer B, Kolominsky-Rabas PL; German Stroke Registers Study Group; Competence Net Stroke.

Stroke. 2003 May;34(5):1106-13. Epub 2003 Mar 27.

14.

Direct access to a hospital offering intravenous thrombolysis therapy improves functional outcome of acute ischemic stroke patients.

Kim DH, Cha JK, Park HS, Choi JH, Kang MJ, Huh JT.

J Clin Neurosci. 2014 Aug;21(8):1428-32. doi: 10.1016/j.jocn.2014.03.014. Epub 2014 Jun 26.

PMID:
24980628
15.

Thrombolysis with recombinant tissue plasminogen activator and tirofiban in stroke: preliminary observations.

Seitz RJ, Hamzavi M, Junghans U, Ringleb PA, Schranz C, Siebler M.

Stroke. 2003 Aug;34(8):1932-5. Epub 2003 Jun 26.

16.
17.

Thrombolytic therapy rates and stroke severity: an analysis of data from the Swedish stroke register (Riks-Stroke) 2007-2010.

Stecksén A, Asplund K, Appelros P, Glader EL, Norrving B, Eriksson M; Riks-Stroke Collaboration.

Stroke. 2012 Feb;43(2):536-8. doi: 10.1161/STROKEAHA.111.630590. Epub 2011 Oct 6.

18.

Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?

Ringleb PA, Schellinger PD, Schranz C, Hacke W.

Stroke. 2002 May;33(5):1437-41. Review.

19.

Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.

Walters MR, Muir KW, Harbison J, Lees KR, Ford GA.

Cerebrovasc Dis. 2005;20(6):438-42. Epub 2005 Oct 17.

PMID:
16230848
20.

Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.

Reinhard M, Wihler C, Roth M, Harloff A, Niesen WD, Timmer J, Weiller C, Hetzel A.

Cerebrovasc Dis. 2008;26(2):147-55. doi: 10.1159/000139662. Epub 2008 Jun 17.

PMID:
18560218
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk